P53 mutations are commoner in left-sided CRC and follow the chromosomal instability molecular pathway [40], where tumorigenesis starts with inactivation of the adenomatous polyposis coli (APC) gene, followed by activation of KRAS and then inactivation of p53 mutations [38,40]. The gene discussed is TP53; the disease is colorectal carcinoma.